Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

US diabetes patients face delays as insurers tighten Ozempic coverage
Reuters
Tue, 12/12/23 - 10:03 am
Tags:
Novo Nordisk, type 2 diabetes, Ozempic, insurers
Could Eli Lilly Beat Novo Nordisk in the Billion-Dollar Weight Loss Market?
Motley Fool
Fri, 12/8/23 - 09:56 am
Tags:
Eli Lilly, Novo Nordisk, weight loss, Wegovy, Zepbound
Adherence to weight-loss drugs is far higher with Wegovy than older medicines
Reuters
Wed, 12/6/23 - 10:36 am
Tags:
Wegovy, Novo Nordisk, weight loss, patient adherence
As Ozempic cases mount, consumer lawyers push to consolidate lawsuits
Reuters
Mon, 12/4/23 - 06:05 pm
Tags:
legal, weight loss, Ozempic, Wegovy, Novo Nordisk, side effects
Maker of Wegovy, Ozempic showers money on U.S. obesity doctors
Reuters
Mon, 12/4/23 - 09:35 am
Tags:
Novo Nordisk, obesity, physicians, Wegovy, Ozempic
US obesity docs expect Lilly weight-loss drug to show similar heart benefit as Wegovy
Reuters
Sun, 12/3/23 - 09:29 pm
Tags:
Eli Lilly, Zepbound, Novo Nordisk, Wegovy
Novo to expand French plant in GLP-1 production push
BioPharma Dive
Tue, 11/28/23 - 10:30 am
Tags:
Novo Nordisk, GLP-1 agonist, France, drug manufacturing
The Next Generation of Weight Loss Drugs is Rapidly Approaching
BioSpace
Mon, 11/20/23 - 11:32 am
Tags:
weightloss, Novo Nordisk, Eli Lilly, Pfizer, AstraZeneca, Wegovy, Zepbound
Novo Nordisk offers staff free Wegovy
Beckers Hospital Review
Fri, 11/17/23 - 11:46 am
Tags:
Novo Nordisk, Wegovy, employee benefits
Manufacturer Lonza says it will not fill obesity drug syringes
Reuters
Fri, 11/17/23 - 10:02 am
Tags:
Lonza, drug manufacturing, obesity, Novo Nordisk, Eli Lilly
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
https://bit.ly/49zNkYL
Wed, 11/15/23 - 12:04 pm
Tags:
Novo Nordisk, Eli Lilly, clinical trials, CagriSema, Wegovy, Zepbound, obesity
German regulator eyes Ozempic export ban amid shortages across Europe
Reuters
Wed, 11/15/23 - 11:19 am
Tags:
Novo Nordisk, Ozempic, Europe, Germany, exporting
Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Fierce Pharma
Mon, 11/13/23 - 12:08 pm
Tags:
Novo Nordisk, Wegovy, heart disease, cardiovascular disease, clinical trials
Wegovy cuts risk of heart attacks in milestone cardiovascular trial
Stat
Sun, 11/12/23 - 09:32 pm
Tags:
Wegovy, Novo Nordisk, clinical trials, cardiovascular disease
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Motley Fool
Sun, 11/12/23 - 09:21 pm
Tags:
Eli Lilly, Zepbound, Novo Nordisk, Wegovy, weightloss
Novo Nordisk sets aside $6bn to boost production capacity
Pharmaphorum
Fri, 11/10/23 - 10:11 am
Tags:
Novo Nordisk, diabetes, obesity, drug manufacturing
Senator floats new models to manage costs of weight loss drugs like Ozempic
Stat
Thu, 11/9/23 - 09:54 am
Tags:
Novo Nordisk, Wegovy, Ozempic, weightloss, Senate, drug pricing
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
Motley Fool
Thu, 11/9/23 - 09:53 am
Tags:
Novo Nordisk, Wegovy, weightloss
Novo Nordisk to discontinue Levemir insulin in U.S. market
Reuters
Wed, 11/8/23 - 09:59 pm
Tags:
Novo Nordisk, Levemir, insulin, diabetes
Novo Nordisk warns EU that new rules will push it to expand faster in US
Financial Times
Sun, 11/5/23 - 11:15 pm
Tags:
Novo Nordisk, Europe

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.